Company Filing History:
Years Active: 2003
Title: Alfred Reidelshoefer: Innovating Pharmaceutical Dosage Forms
Introduction
Alfred Reidelshoefer, a notable inventor from Michelstadt, Germany, has made significant contributions to the field of pharmaceuticals. With a focus on enhancing medication delivery systems, he has successfully earned a patent that underlines his innovative approach.
Latest Patents
Reidelshoefer's most prominent patent is related to a stable pharmaceutical dosage form for paroxetine anhydrate. This invention comprises medicaments in the form of soft gelatin capsules which contain paroxetine anhydrate or pharmaceutically acceptable salts, complemented by lipophilic carriers such as silicone oils. This advancement not only improves the stability of the drug but also enhances its efficacy.
Career Highlights
Reidelshoefer is associated with BASF Aktiengesellschaft, a leading chemical company renowned for its cutting-edge research and development in various industries, including healthcare. His work at BASF focuses on pushing the boundaries of pharmaceutical innovations, aiming to deliver better therapeutic options for patients.
Collaborations
Throughout his career, Reidelshoefer has collaborated with esteemed coworkers, including Heinz Einig and Gerhard Fischer. These partnerships have been instrumental in fostering a creative environment that promotes pioneering ideas and solutions in pharmaceutical sciences.
Conclusion
Alfred Reidelshoefer's inventive spirit and dedication to improving drug formulation are evident through his patent achievements. His work not only contributes to the ongoing evolution of pharmaceuticals but also positions him as a key player in the industry. As innovations continue to shape the future of healthcare, inventors like Reidelshoefer remain vital in crafting solutions that benefit society.